Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 01, 2025 Filed Nov 4, 2025 22:00 UTC |
Farag Kameel D.Interim CFO
|
GrantAmerican Depositary Shares representing Ordinary Shares | 32,000 | $0.75 | $24,000.00 |
DisclosureSEC source: 0001493152-25-020753 · ownership.xml · nonDerivative · entry 1 Farag Kameel D. · CIK 0002093620 · Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,000 F1 · security: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer F2 · shares: These ADSs represent restricted stock units ("RSUs"), with each such RSU representing the right to receive 2,000 Ordinary Shares par value $0.0001. The RSUs shall vest on January 1, 2026. Read SEC document |
| October 22, 2025 Filed Oct 24, 2025 13:18 UTC |
Farag Kameel D.Interim CFO
|
GrantAmerican Depositary Shares representing Ordinary Shares | 6,277 | $0.74 | $4,644.98 |
DisclosureSEC source: 0001493152-25-019194 · ownership.xml · nonDerivative · entry 1 Farag Kameel D. · CIK 0002093620 · Interim CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,277 F1 · security: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer F2 · shares: These ADSs represent restricted stock units ("RSUs"), with each such RSU representing the right to receive 2,000 Ordinary Shares par value $0.0001. The RSUs shall vest on October 31, 2025. Read SEC document |
| August 25, 2025 Filed Aug 29, 2025 20:55 UTC |
Gaslightwala AbizerDirector · CEO
|
PurchaseAmerican Depositary Shares representing Ordinary Shares | 3,000 | $0.90 | $2,700.00 |
DisclosureSEC source: 0001641172-25-026025 · ownership.xml · nonDerivative · entry 3 Gaslightwala Abizer · CIK 0002049375 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 298,574 F1 · security: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer. F4 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.89 to $0.90, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within ranges set forth in this footnote. Read SEC document |
| August 22, 2025 Filed Aug 29, 2025 20:55 UTC |
Gaslightwala AbizerDirector · CEO
|
PurchaseAmerican Depositary Shares representing Ordinary Shares | 8,000 | $0.93 | $7,440.00 |
DisclosureSEC source: 0001641172-25-026025 · ownership.xml · nonDerivative · entry 2 Gaslightwala Abizer · CIK 0002049375 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 295,574 F1 · security: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer. F3 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.92 to $0.93, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within ranges set forth in this footnote. Read SEC document |
| August 21, 2025 Filed Aug 29, 2025 20:55 UTC |
Gaslightwala AbizerDirector · CEO
|
PurchaseAmerican Depositary Shares representing Ordinary Shares | 10,000 | $0.94 | $9,400.00 |
DisclosureSEC source: 0001641172-25-026025 · ownership.xml · nonDerivative · entry 1 Gaslightwala Abizer · CIK 0002049375 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 287,574 F1 · security: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer. F2 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.93 to $0.94, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within ranges set forth in this footnote. Read SEC document |
| June 24, 2025 Filed Jun 25, 2025 20:30 UTC |
Gaslightwala AbizerDirector · President & CEO
|
PurchaseAmerican Depositary Shares representing Ordinary Shares | 5,203 | $1.16 | $6,035.48 |
DisclosureSEC source: 0000950170-25-089976 · ownership.xml · nonDerivative · entry 2 Gaslightwala Abizer · CIK 0002049375 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 277,574 F1 · security: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer. F2 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.15 to $1.16, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within ranges set forth in this footnote. Read SEC document |
| June 23, 2025 Filed Jun 25, 2025 20:30 UTC |
Gaslightwala AbizerDirector · President & CEO
|
PurchaseAmerican Depositary Shares representing Ordinary Shares | 943 | $1.15 | $1,084.45 |
DisclosureSEC source: 0000950170-25-089976 · ownership.xml · nonDerivative · entry 1 Gaslightwala Abizer · CIK 0002049375 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 272,371 F1 · security: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer. Read SEC document |
| June 20, 2025 Filed Jun 24, 2025 20:30 UTC |
Gaslightwala AbizerDirector · President & CEO
|
PurchaseAmerican Depositary Shares representing Ordinary Shares | 10,000 | $1.20 | $12,000.00 |
DisclosureSEC source: 0000950170-25-089462 · ownership.xml · nonDerivative · entry 1 Gaslightwala Abizer · CIK 0002049375 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 271,428 F1 · security: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer. Read SEC document |
| June 17, 2025 Filed Jun 20, 2025 20:05 UTC |
Gaslightwala AbizerDirector · President & CEO
|
PurchaseAmerican Depositary Shares representing Ordinary Shares | 15,000 | $1.20 | $18,000.00 |
DisclosureSEC source: 0000950170-25-088490 · ownership.xml · nonDerivative · entry 1 Gaslightwala Abizer · CIK 0002049375 · Director · President & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 261,428 F1 · security: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer. Read SEC document |
| June 13, 2025 Filed Jun 16, 2025 21:00 UTC |
Gaslightwala AbizerDirector · CEO
|
GrantAmerican Depositary Shares representing Ordinary Shares | 25,000 | $1.19 | $29,750.00 |
DisclosureSEC source: 0000950170-25-086829 · ownership.xml · nonDerivative · entry 2 Gaslightwala Abizer · CIK 0002049375 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 246,428 F1 · security: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer. F3 · kind: On June 13, 2025, the Reporting Person acquired 10,000 ADS at an average price of $1.19 per ADS. F3 · price: On June 13, 2025, the Reporting Person acquired 10,000 ADS at an average price of $1.19 per ADS. Read SEC document |
| June 12, 2025 Filed Jun 16, 2025 21:00 UTC |
Gaslightwala AbizerDirector · CEO
|
GrantAmerican Depositary Shares representing Ordinary Shares | 20,000 | $1.23 | $24,600.00 |
DisclosureSEC source: 0000950170-25-086829 · ownership.xml · nonDerivative · entry 1 Gaslightwala Abizer · CIK 0002049375 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 221,428 F1 · security: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer. F2 · kind: On June 12, 2025, the Reporting Person acquired 20,000 ADS at an average price of $1.23 per ADS. F2 · price: On June 12, 2025, the Reporting Person acquired 20,000 ADS at an average price of $1.23 per ADS. Read SEC document |
| June 10, 2025 Filed Jun 12, 2025 20:30 UTC |
Gaslightwala AbizerDirector · CEO
|
GrantAmerican Depositary Shares representing Ordinary Shares | 20,000 | $1.27 | $25,400.00 |
DisclosureSEC source: 0000950170-25-085472 · ownership.xml · nonDerivative · entry 1 Gaslightwala Abizer · CIK 0002049375 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 201,428 F1 · security: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer. F2 · kind: On June 10, 2025, the Reporting Person acquired 20,000 ADS at an average price of $1.27 per ADS. F2 · price: On June 10, 2025, the Reporting Person acquired 20,000 ADS at an average price of $1.27 per ADS. Read SEC document |
| March 20, 2025 Filed Mar 24, 2025 21:00 UTC |
Patel Sandip IDirector
|
GrantStock Option (Right to Buy) · Derivative | 225,000 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0000950170-25-043935 · ownership.xml · derivative · entry 7 Patel Sandip I · CIK 0001843601 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 225,000 Underlying: American Depositary Shares representing Ordinary Shares · 225,000 shares Expires 2035-03-20 F3 · derivative.exercise_date: The stock option award was granted under the Issuer's 2023 Equity Incentive Plan. Subject to the Reporting Person's continued service with the Issuer and shareholder approval covering the issuance of the ADS underlying this stock option, this option shall vest (i) 25% on the grant date (ii) 25% on December 31, 2025 and (iii) the remaining 50% shall vest ratably on a monthly basis over the 24 month period thereafter. F1 · derivative.underlying: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer. Read SEC document |
| March 20, 2025 Filed Mar 24, 2025 21:00 UTC |
Patel Sandip IDirector
|
GrantStock Option (Right to Buy) · Derivative | 175,000 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0000950170-25-043935 · ownership.xml · derivative · entry 6 Patel Sandip I · CIK 0001843601 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 175,000 Underlying: American Depositary Shares representing Ordinary Shares · 175,000 shares Expires 2035-03-20 F2 · derivative.exercise_date: The stock option award was granted under the Issuer's 2023 Equity Incentive Plan. The stock option shall vest over four years from the grant date with 25% vesting on the 12 month anniversary of the grant date, and the remainder vesting ratably on a monthly basis over the then remaining 36 months from the grant date, such that it will be fully vested on the fourth anniversary of the grant date. The stock option award is subject to continued service with the Issuer. F1 · derivative.underlying: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer. Read SEC document |
| March 20, 2025 Filed Mar 24, 2025 21:00 UTC |
Gaslightwala AbizerDirector
|
GrantStock Option (Right to Buy) · Derivative | 600,000 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0000950170-25-043933 · ownership.xml · derivative · entry 3 Gaslightwala Abizer · CIK 0002049375 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 600,000 Underlying: American Depositary Shares representing Ordinary Shares · 600,000 shares Expires 2035-03-20 F3 · derivative.exercise_date: The stock option award was granted under the Issuer's 2023 Equity Incentive Plan. The stock options shall vest upon achievement of at least one of the following performance criteria: either (a) closing of a qualified financing of at least $15,000,000 in gross proceeds on or before December 31, 2025, or (b) closing of an antibody drug conjugate ("ADC") focused license transaction, with a minimum upfront payment of $10,000,000 on or before December 31, 2025. If neither of these criteria are met by December 31, 2025 the performance-based option will expire. The stock option award is subject to continued service with the Issuer. F1 · derivative.underlying: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer. Read SEC document |
| March 20, 2025 Filed Mar 24, 2025 21:00 UTC |
Gaslightwala AbizerDirector
|
GrantStock Option (Right to Buy) · Derivative | 1,100,000 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0000950170-25-043933 · ownership.xml · derivative · entry 2 Gaslightwala Abizer · CIK 0002049375 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,100,000 Underlying: American Depositary Shares representing Ordinary Shares · 1,100,000 shares Expires 2035-03-20 F2 · derivative.exercise_date: The stock option award was granted under the Issuer's 2023 Equity Incentive Plan. The stock option shall vest over four years from the grant date with 25% vesting on the 12 month anniversary of the grant date, and the remainder vesting ratably on a monthly basis over the then remaining 36 months from the grant date, such that it will be fully vested on the fourth anniversary of the grant date. The stock option award is subject to continued service with the Issuer. F1 · derivative.underlying: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer. Read SEC document |
| March 20, 2025 Filed Mar 24, 2025 17:00 UTC |
Huh HoyoungDirector · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 225,000 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0000950170-25-043936 · ownership.xml · derivative · entry 4 Huh Hoyoung · CIK 0001401267 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 225,000 Underlying: American Depositary Shares representing Ordinary Shares · 225,000 shares Expires 2035-03-20 F3 · derivative.exercise_date: The stock option award was granted under the Issuer's 2023 Equity Incentive Plan. Subject to the Reporting Person's continued service with the Issuer and shareholder approval covering the issuance of the ADS underlying this stock option, this option shall vest (i) 25% on the grant date (ii) 25% on December 31, 2025 and (iii) the remaining 50% shall vest ratably on a monthly basis over the 24 month period thereafter. F1 · derivative.underlying: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer. Read SEC document |
| March 20, 2025 Filed Mar 24, 2025 17:00 UTC |
Huh HoyoungDirector · 10% owner
|
GrantStock Option (Right to Buy) · Derivative | 175,000 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0000950170-25-043936 · ownership.xml · derivative · entry 3 Huh Hoyoung · CIK 0001401267 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 175,000 Underlying: American Depositary Shares representing Ordinary Shares · 175,000 shares Expires 2035-03-20 F2 · derivative.exercise_date: The stock option award was granted under the Issuer's 2023 Equity Incentive Plan. The stock option shall vest over four years from the grant date with 25% vesting on the 12 month anniversary of the grant date, and the remainder vesting ratably on a monthly basis over the then remaining 36 months from the grant date, such that it will be fully vested on the fourth anniversary of the grant date. The stock option award is subject to continued service with the Issuer. F1 · derivative.underlying: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer. Read SEC document |
| March 20, 2025 Filed Mar 24, 2025 21:00 UTC |
Neal James RDirector
|
GrantStock Option (Right to Buy) · Derivative | 225,000 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0000950170-25-043940 · ownership.xml · derivative · entry 3 Neal James R · CIK 0001600865 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 225,000 Underlying: American Depositary Shares representing Ordinary Shares · 225,000 shares Expires 2035-03-20 F3 · derivative.exercise_date: The stock option award was granted under the Issuer's 2023 Equity Incentive Plan. Subject to the Reporting Person's continued service with the Issuer and shareholder approval covering the issuance of the ADS underlying this stock option, this option shall vest (i) 25% on the grant date (ii) 25% on December 31, 2025 and (iii) the remaining 50% shall vest ratably on a monthly basis over the 24 month period thereafter. F1 · derivative.underlying: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer. Read SEC document |
| March 20, 2025 Filed Mar 24, 2025 21:00 UTC |
Neal James RDirector
|
GrantStock Option (Right to Buy) · Derivative | 175,000 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0000950170-25-043940 · ownership.xml · derivative · entry 2 Neal James R · CIK 0001600865 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 175,000 Underlying: American Depositary Shares representing Ordinary Shares · 175,000 shares Expires 2035-03-20 F2 · derivative.exercise_date: The stock option award was granted under the Issuer's 2023 Equity Incentive Plan. The stock option shall vest over four years from the grant date with 25% vesting on the 12 month anniversary of the grant date, and the remainder vesting ratably on a monthly basis over the then remaining 36 months from the grant date, such that it will be fully vested on the fourth anniversary of the grant date. The stock option award is subject to continued service with the Issuer. F1 · derivative.underlying: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer. Read SEC document |
| March 20, 2025 Filed Mar 24, 2025 21:00 UTC |
Bazemore Robert BDirector
|
GrantStock Option (Right to Buy) · Derivative | 225,000 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0000950170-25-043939 · ownership.xml · derivative · entry 3 Bazemore Robert B · CIK 0001620152 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 225,000 Underlying: American Depositary Shares representing Ordinary Shares · 225,000 shares Expires 2035-03-20 F3 · derivative.exercise_date: The stock option award was granted under the Issuer's 2023 Equity Incentive Plan. Subject to the Reporting Person's continued service with the Issuer and shareholder approval covering the issuance of the ADS underlying this stock option, this option shall vest (i) 25% on the grant date (ii) 25% on December 31, 2025 and (iii) the remaining 50% shall vest ratably on a monthly basis over the 24 month period thereafter. F1 · derivative.underlying: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer. Read SEC document |
| March 20, 2025 Filed Mar 24, 2025 21:00 UTC |
Bazemore Robert BDirector
|
GrantStock Option (Right to Buy) · Derivative | 175,000 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0000950170-25-043939 · ownership.xml · derivative · entry 2 Bazemore Robert B · CIK 0001620152 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 175,000 Underlying: American Depositary Shares representing Ordinary Shares · 175,000 shares Expires 2035-03-20 F2 · derivative.exercise_date: The stock option award was granted under the Issuer's 2023 Equity Incentive Plan. The stock option shall vest over four years from the grant date with 25% vesting on the 12 month anniversary of the grant date, and the remainder vesting ratably on a monthly basis over the then remaining 36 months from the grant date, such that it will be fully vested on the fourth anniversary of the grant date. The stock option award is subject to continued service with the Issuer. F1 · derivative.underlying: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer. Read SEC document |
| March 20, 2025 Filed Mar 24, 2025 21:00 UTC |
Patel Samir RashmikantDirector
|
GrantStock Option (Right to Buy) · Derivative | 225,000 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0000950170-25-043938 · ownership.xml · derivative · entry 4 Patel Samir Rashmikant · CIK 0001702447 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 225,000 Underlying: American Depositary Shares representing Ordinary Shares · 225,000 shares Expires 2035-03-20 F3 · derivative.exercise_date: The stock option award was granted under the Issuer's 2023 Equity Incentive Plan. Subject to the Reporting Person's continued service with the Issuer and shareholder approval covering the issuance of the ADS underlying this stock option, this option shall vest (i) 25% on the grant date (ii) 25% on December 31, 2025 and (iii) the remaining 50% shall vest ratably on a monthly basis over the 24 month period thereafter. F1 · derivative.underlying: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer. Read SEC document |
| March 20, 2025 Filed Mar 24, 2025 21:00 UTC |
Patel Samir RashmikantDirector
|
GrantStock Option (Right to Buy) · Derivative | 175,000 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0000950170-25-043938 · ownership.xml · derivative · entry 3 Patel Samir Rashmikant · CIK 0001702447 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 175,000 Underlying: American Depositary Shares representing Ordinary Shares · 175,000 shares Expires 2035-03-20 F2 · derivative.exercise_date: The stock option award was granted under the Issuer's 2023 Equity Incentive Plan. The stock option shall vest over four years from the grant date with 25% vesting on the 12 month anniversary of the grant date, and the remainder vesting ratably on a monthly basis over the then remaining 36 months from the grant date, such that it will be fully vested on the fourth anniversary of the grant date. The stock option award is subject to continued service with the Issuer. F1 · derivative.underlying: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer. Read SEC document |
| March 20, 2025 Filed Mar 24, 2025 21:00 UTC |
Prudo-Chlebosz RaymondDirector
|
GrantStock Option (Right to Buy) · Derivative | 225,000 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0000950170-25-043937 · ownership.xml · derivative · entry 5 Prudo-Chlebosz Raymond · CIK 0001653262 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 225,000 Underlying: American Depositary Shares representing Ordinary Shares · 225,000 shares Expires 2035-03-20 F3 · derivative.exercise_date: The stock option award was granted under the Issuer's 2023 Equity Incentive Plan. Subject to the Reporting Person's continued service with the Issuer and shareholder approval covering the issuance of the ADS underlying this stock option, this option shall vest (i) 25% on the grant date (ii) 25% on December 31, 2025 and (iii) the remaining 50% shall vest ratably on a monthly basis over the 24 month period thereafter. F1 · derivative.underlying: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer. Read SEC document |
| March 20, 2025 Filed Mar 24, 2025 21:00 UTC |
Prudo-Chlebosz RaymondDirector
|
GrantStock Option (Right to Buy) · Derivative | 175,000 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0000950170-25-043937 · ownership.xml · derivative · entry 4 Prudo-Chlebosz Raymond · CIK 0001653262 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 175,000 Underlying: American Depositary Shares representing Ordinary Shares · 175,000 shares Expires 2035-03-20 F2 · derivative.exercise_date: The stock option award was granted under the Issuer's 2023 Equity Incentive Plan. The stock option shall vest over four years from the grant date with 25% vesting on the 12 month anniversary of the grant date, and the remainder vesting ratably on a monthly basis over the then remaining 36 months from the grant date, such that it will be fully vested on the fourth anniversary of the grant date. The stock option award is subject to continued service with the Issuer. F1 · derivative.underlying: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer. Read SEC document |
| March 20, 2025 Filed Mar 24, 2025 21:00 UTC | GrantStock Option (Right to Buy) · Derivative | 200,000 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0000950170-25-043934 · ownership.xml · derivative · entry 3 Hombeck Torsten · CIK 0001983682 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,000 Underlying: American Depositary Shares representing Ordinary Shares · 200,000 shares Expires 2035-03-20 F3 · derivative.exercise_date: The stock option award was granted under the Issuer's 2023 Equity Incentive Plan. The stock options shall vest upon achievement of at least one of the following performance criteria: either (a) closing of a qualified financing of at least $15,000,000 in gross proceeds on or before December 31, 2025, or (b) closing of an antibody drug conjugate ("ADC") focused license transaction, with a minimum upfront payment of $10,000,000 on or before December 31, 2025. If neither of these criteria are met by December 31, 2025 the performance-based option will expire. The stock option award is subject to continued service with the Issuer. F1 · derivative.underlying: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer. Read SEC document |
|
| March 20, 2025 Filed Mar 24, 2025 21:00 UTC | GrantStock Option (Right to Buy) · Derivative | 300,000 | $0.00 Strike: $1.50 | $0.00 |
DisclosureSEC source: 0000950170-25-043934 · ownership.xml · derivative · entry 2 Hombeck Torsten · CIK 0001983682 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300,000 Underlying: American Depositary Shares representing Ordinary Shares · 300,000 shares Expires 2035-03-20 F2 · derivative.exercise_date: The stock option award was granted under the Issuer's 2023 Equity Incentive Plan. The stock option shall vest over four years from the grant date with 25% vesting on the 12 month anniversary of the grant date, and the remainder vesting ratably on a monthly basis over the then remaining 36 months from the grant date, such that it will be fully vested on the fourth anniversary of the grant date. The stock option award is subject to continued service with the Issuer. F1 · derivative.underlying: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer. Read SEC document |
|
| March 06, 2025 Filed Mar 10, 2025 21:00 UTC |
Gaslightwala AbizerDirector
|
GrantSeries B Warrants (Right to Buy) · Derivative | 133,928 | $1.12 Strike: $0.87 | $149,999.36 |
DisclosureSEC source: 0000950170-25-036483 · ownership.xml · derivative · entry 3 Gaslightwala Abizer · CIK 0002049375 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 133,928 Underlying: American Depositary Shares representing Ordinary Shares · 133,928 shares Expires 2030-03-06 F2 · kind: On March 6, 2025, the Reporting Person acquired 133,928 ADS and accompanying Series A and Series B warrants to purchase up to 267,856 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant. F2 · price: On March 6, 2025, the Reporting Person acquired 133,928 ADS and accompanying Series A and Series B warrants to purchase up to 267,856 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant. F1 · derivative.underlying: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer. Read SEC document |
| March 06, 2025 Filed Mar 10, 2025 21:00 UTC |
Gaslightwala AbizerDirector
|
GrantSeries A Warrants (Right to Buy) · Derivative | 133,928 | $1.12 Strike: $0.87 | $149,999.36 |
DisclosureSEC source: 0000950170-25-036483 · ownership.xml · derivative · entry 2 Gaslightwala Abizer · CIK 0002049375 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 133,928 Underlying: American Depositary Shares representing Ordinary Shares · 133,928 shares Expires 2026-03-06 F2 · kind: On March 6, 2025, the Reporting Person acquired 133,928 ADS and accompanying Series A and Series B warrants to purchase up to 267,856 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant. F2 · price: On March 6, 2025, the Reporting Person acquired 133,928 ADS and accompanying Series A and Series B warrants to purchase up to 267,856 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant. F1 · derivative.underlying: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer. Read SEC document |
| March 06, 2025 Filed Mar 10, 2025 21:00 UTC |
Gaslightwala AbizerDirector
|
GrantAmerican Depositary Shares representing Ordinary Shares | 133,928 | $1.12 | $149,999.36 |
DisclosureSEC source: 0000950170-25-036483 · ownership.xml · nonDerivative · entry 1 Gaslightwala Abizer · CIK 0002049375 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 181,428 F1 · security: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer. F2 · kind: On March 6, 2025, the Reporting Person acquired 133,928 ADS and accompanying Series A and Series B warrants to purchase up to 267,856 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant. F2 · price: On March 6, 2025, the Reporting Person acquired 133,928 ADS and accompanying Series A and Series B warrants to purchase up to 267,856 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant. Read SEC document |
| March 06, 2025 Filed Mar 10, 2025 17:00 UTC |
Huh HoyoungDirector · 10% owner
|
GrantSeries B Warrants (Right to Buy) · Derivative | 892,857 | $1.12 Strike: $0.87 | $999,999.84 |
DisclosureSEC source: 0000950170-25-036488 · ownership.xml · derivative · entry 4 Huh Hoyoung · CIK 0001401267 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 892,857 Underlying: American Depositary Shares representing Ordinary Shares · 892,857 shares Expires 2030-03-06 F2 · kind: On March 6, 2025, the Reporting Person acquired 892,857 ADS and accompanying Series A and Series B warrants to purchase up to 1,785,714 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant. F2 · price: On March 6, 2025, the Reporting Person acquired 892,857 ADS and accompanying Series A and Series B warrants to purchase up to 1,785,714 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant. F1 · derivative.underlying: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer. Read SEC document |
| March 06, 2025 Filed Mar 10, 2025 17:00 UTC |
Huh HoyoungDirector · 10% owner
|
GrantSeries A Warrants (Right to Buy) · Derivative | 892,857 | $1.12 Strike: $0.87 | $999,999.84 |
DisclosureSEC source: 0000950170-25-036488 · ownership.xml · derivative · entry 3 Huh Hoyoung · CIK 0001401267 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 892,857 Underlying: American Depositary Shares representing Ordinary Shares · 892,857 shares Expires 2026-03-06 F2 · kind: On March 6, 2025, the Reporting Person acquired 892,857 ADS and accompanying Series A and Series B warrants to purchase up to 1,785,714 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant. F2 · price: On March 6, 2025, the Reporting Person acquired 892,857 ADS and accompanying Series A and Series B warrants to purchase up to 1,785,714 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant. F1 · derivative.underlying: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer. Read SEC document |
| March 06, 2025 Filed Mar 10, 2025 17:00 UTC |
Huh HoyoungDirector · 10% owner
|
GrantAmerican Depositary Shares representing Ordinary Shares | 892,857 | $1.12 | $999,999.84 |
DisclosureSEC source: 0000950170-25-036488 · ownership.xml · nonDerivative · entry 1 Huh Hoyoung · CIK 0001401267 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,695,854 F1 · security: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer. F2 · kind: On March 6, 2025, the Reporting Person acquired 892,857 ADS and accompanying Series A and Series B warrants to purchase up to 1,785,714 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant. F2 · price: On March 6, 2025, the Reporting Person acquired 892,857 ADS and accompanying Series A and Series B warrants to purchase up to 1,785,714 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant. Read SEC document |
| March 06, 2025 Filed Mar 10, 2025 21:00 UTC |
Prudo-Chlebosz RaymondDirector
|
GrantSeries B Warrants (Right to Buy) · Derivative | 446,428 | $1.12 Strike: $0.87 | $499,999.36 |
DisclosureSEC source: 0000950170-25-036487 · ownership.xml · derivative · entry 5 Prudo-Chlebosz Raymond · CIK 0001653262 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 446,428 Underlying: American Depositary Shares representing Ordinary Shares · 446,428 shares Expires 2030-03-06 F2 · kind: On March 6, 2025, the Reporting Person acquired 446,428 ADS and accompanying Series A and Series B warrants to purchase up to 892,856 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant. F2 · price: On March 6, 2025, the Reporting Person acquired 446,428 ADS and accompanying Series A and Series B warrants to purchase up to 892,856 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant. F1 · derivative.underlying: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer. Read SEC document |
| March 06, 2025 Filed Mar 10, 2025 21:00 UTC |
Prudo-Chlebosz RaymondDirector
|
GrantSeries A Warrants (Right to Buy) · Derivative | 446,428 | $1.12 Strike: $0.87 | $499,999.36 |
DisclosureSEC source: 0000950170-25-036487 · ownership.xml · derivative · entry 4 Prudo-Chlebosz Raymond · CIK 0001653262 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 446,428 Underlying: American Depositary Shares representing Ordinary Shares · 446,428 shares Expires 2026-03-06 F2 · kind: On March 6, 2025, the Reporting Person acquired 446,428 ADS and accompanying Series A and Series B warrants to purchase up to 892,856 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant. F2 · price: On March 6, 2025, the Reporting Person acquired 446,428 ADS and accompanying Series A and Series B warrants to purchase up to 892,856 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant. F1 · derivative.underlying: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer. Read SEC document |
| March 06, 2025 Filed Mar 10, 2025 21:00 UTC |
Prudo-Chlebosz RaymondDirector
|
GrantAmerican Depositary Shares representing Ordinary Shares | 446,428 | $1.12 | $499,999.36 |
DisclosureSEC source: 0000950170-25-036487 · ownership.xml · nonDerivative · entry 1 Prudo-Chlebosz Raymond · CIK 0001653262 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,484,990 F1 · security: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer. F2 · kind: On March 6, 2025, the Reporting Person acquired 446,428 ADS and accompanying Series A and Series B warrants to purchase up to 892,856 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant. F2 · price: On March 6, 2025, the Reporting Person acquired 446,428 ADS and accompanying Series A and Series B warrants to purchase up to 892,856 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant. Read SEC document |
| March 06, 2025 Filed Mar 10, 2025 21:00 UTC |
Patel Samir RashmikantDirector
|
GrantSeries B Warrants (Right to Buy) · Derivative | 406,250 | $1.12 Strike: $0.87 | $455,000.00 |
DisclosureSEC source: 0000950170-25-036486 · ownership.xml · derivative · entry 4 Patel Samir Rashmikant · CIK 0001702447 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · PranaBio Investments LLC Disclosed balance after: 406,250 Underlying: American Depositary Shares representing Ordinary Shares · 406,250 shares Expires 2030-03-06 F2 · kind: On March 6, 2025, the Reporting Person acquired 406,250 ADS and accompanying Series A and Series B warrants to purchase up to 812,500 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant. F2 · price: On March 6, 2025, the Reporting Person acquired 406,250 ADS and accompanying Series A and Series B warrants to purchase up to 812,500 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant. F1 · derivative.underlying: Each American Depository Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer. Read SEC document |
| March 06, 2025 Filed Mar 10, 2025 21:00 UTC |
Patel Samir RashmikantDirector
|
GrantSeries A Warrants (Right to Buy) · Derivative | 406,250 | $1.12 Strike: $0.87 | $455,000.00 |
DisclosureSEC source: 0000950170-25-036486 · ownership.xml · derivative · entry 3 Patel Samir Rashmikant · CIK 0001702447 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · PranaBio Investments LLC Disclosed balance after: 406,250 Underlying: American Depositary Shares representing Ordinary Shares · 406,250 shares Expires 2026-03-06 F2 · kind: On March 6, 2025, the Reporting Person acquired 406,250 ADS and accompanying Series A and Series B warrants to purchase up to 812,500 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant. F2 · price: On March 6, 2025, the Reporting Person acquired 406,250 ADS and accompanying Series A and Series B warrants to purchase up to 812,500 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant. F1 · derivative.underlying: Each American Depository Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer. Read SEC document |
| March 06, 2025 Filed Mar 10, 2025 21:00 UTC |
Patel Samir RashmikantDirector
|
GrantAmerican Depositary Shares representing Ordinary Shares | 406,250 | $1.12 | $455,000.00 |
DisclosureSEC source: 0000950170-25-036486 · ownership.xml · nonDerivative · entry 1 Patel Samir Rashmikant · CIK 0001702447 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · PranaBio Investments LLC Disclosed balance after: 3,031,005 F1 · security: Each American Depository Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer. F2 · kind: On March 6, 2025, the Reporting Person acquired 406,250 ADS and accompanying Series A and Series B warrants to purchase up to 812,500 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant. F2 · price: On March 6, 2025, the Reporting Person acquired 406,250 ADS and accompanying Series A and Series B warrants to purchase up to 812,500 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant. Read SEC document |
| March 06, 2025 Filed Mar 10, 2025 21:00 UTC |
Neal James RDirector
|
GrantSeries B Warrants (Right to Buy) · Derivative | 4,464 | $1.12 Strike: $0.87 | $4,999.68 |
DisclosureSEC source: 0000950170-25-036485 · ownership.xml · derivative · entry 3 Neal James R · CIK 0001600865 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,464 Underlying: American Depositary Shares representing Ordinary Shares · 4,464 shares Expires 2030-03-06 F2 · kind: On March 6, 2025, the Reporting Person acquired 4,464 ADS and accompanying Series A and Series B warrants to purchase up to 8,928 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant. F2 · price: On March 6, 2025, the Reporting Person acquired 4,464 ADS and accompanying Series A and Series B warrants to purchase up to 8,928 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant. F1 · derivative.underlying: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer. Read SEC document |
| March 06, 2025 Filed Mar 10, 2025 21:00 UTC |
Neal James RDirector
|
GrantSeries A Warrants (Right to Buy) · Derivative | 4,464 | $1.12 Strike: $0.87 | $4,999.68 |
DisclosureSEC source: 0000950170-25-036485 · ownership.xml · derivative · entry 2 Neal James R · CIK 0001600865 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,464 Underlying: American Depositary Shares representing Ordinary Shares · 4,464 shares Expires 2026-03-06 F2 · kind: On March 6, 2025, the Reporting Person acquired 4,464 ADS and accompanying Series A and Series B warrants to purchase up to 8,928 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant. F2 · price: On March 6, 2025, the Reporting Person acquired 4,464 ADS and accompanying Series A and Series B warrants to purchase up to 8,928 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant. F1 · derivative.underlying: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer. Read SEC document |
| March 06, 2025 Filed Mar 10, 2025 21:00 UTC |
Neal James RDirector
|
GrantAmerican Depositary Shares representing Ordinary Shares | 4,464 | $1.12 | $4,999.68 |
DisclosureSEC source: 0000950170-25-036485 · ownership.xml · nonDerivative · entry 1 Neal James R · CIK 0001600865 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,271 F1 · security: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer. F2 · kind: On March 6, 2025, the Reporting Person acquired 4,464 ADS and accompanying Series A and Series B warrants to purchase up to 8,928 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant. F2 · price: On March 6, 2025, the Reporting Person acquired 4,464 ADS and accompanying Series A and Series B warrants to purchase up to 8,928 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant. Read SEC document |
| March 06, 2025 Filed Mar 10, 2025 21:00 UTC |
Bazemore Robert BDirector
|
GrantSeries B Warrants (Right to Buy) · Derivative | 44,642 | $1.12 Strike: $0.87 | $49,999.04 |
DisclosureSEC source: 0000950170-25-036482 · ownership.xml · derivative · entry 3 Bazemore Robert B · CIK 0001620152 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,642 Underlying: American Depositary Shares representing Ordinary Shares · 44,642 shares Expires 2030-03-06 F2 · kind: On March 6, 2025, the Reporting Person acquired 44,642 ADS and accompanying Series A and Series B warrants to purchase up to 89,284 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant. F2 · price: On March 6, 2025, the Reporting Person acquired 44,642 ADS and accompanying Series A and Series B warrants to purchase up to 89,284 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant. F1 · derivative.underlying: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer. Read SEC document |
| March 06, 2025 Filed Mar 10, 2025 21:00 UTC |
Bazemore Robert BDirector
|
GrantSeries A Warrants (Right to Buy) · Derivative | 44,642 | $1.12 Strike: $0.87 | $49,999.04 |
DisclosureSEC source: 0000950170-25-036482 · ownership.xml · derivative · entry 2 Bazemore Robert B · CIK 0001620152 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,642 Underlying: American Depositary Shares representing Ordinary Shares · 44,642 shares Expires 2026-03-06 F2 · kind: On March 6, 2025, the Reporting Person acquired 44,642 ADS and accompanying Series A and Series B warrants to purchase up to 89,284 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant. F2 · price: On March 6, 2025, the Reporting Person acquired 44,642 ADS and accompanying Series A and Series B warrants to purchase up to 89,284 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant. F1 · derivative.underlying: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer. Read SEC document |
| March 06, 2025 Filed Mar 10, 2025 21:00 UTC |
Bazemore Robert BDirector
|
GrantAmerican Depositary Shares representing Ordinary Shares | 44,642 | $1.12 | $49,999.04 |
DisclosureSEC source: 0000950170-25-036482 · ownership.xml · nonDerivative · entry 1 Bazemore Robert B · CIK 0001620152 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,642 F1 · security: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer. F2 · kind: On March 6, 2025, the Reporting Person acquired 44,642 ADS and accompanying Series A and Series B warrants to purchase up to 89,284 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant. F2 · price: On March 6, 2025, the Reporting Person acquired 44,642 ADS and accompanying Series A and Series B warrants to purchase up to 89,284 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant. Read SEC document |
| March 06, 2025 Filed Apr 29, 2025 21:00 UTC |
Patel Sandip IDirector
|
GrantSeries B Warrants (Right to Buy) · Derivative | 44,642 | $1.12 Strike: $0.87 | $49,999.04 |
DisclosureSEC source: 0000950170-25-060298 · ownership.xml · derivative · entry 7 Patel Sandip I · CIK 0001843601 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,642 Underlying: American Depositary Shares representing Ordinary Shares · 44,642 shares Expires 2030-03-06 F2 · kind: On April 25, 2025, the Reporting Person acquired 44,642 ADS and accompanying Series A and Series B warrants to purchase up to 89,284 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant. F2 · price: On April 25, 2025, the Reporting Person acquired 44,642 ADS and accompanying Series A and Series B warrants to purchase up to 89,284 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant. F1 · derivative.underlying: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer. Read SEC document |
| March 06, 2025 Filed Apr 29, 2025 21:00 UTC |
Patel Sandip IDirector
|
GrantSeries A Warrants (Right to Buy) · Derivative | 44,642 | $1.12 Strike: $0.87 | $49,999.04 |
DisclosureSEC source: 0000950170-25-060298 · ownership.xml · derivative · entry 6 Patel Sandip I · CIK 0001843601 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 44,642 Underlying: American Depositary Shares representing Ordinary Shares · 44,642 shares Expires 2026-03-06 F2 · kind: On April 25, 2025, the Reporting Person acquired 44,642 ADS and accompanying Series A and Series B warrants to purchase up to 89,284 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant. F2 · price: On April 25, 2025, the Reporting Person acquired 44,642 ADS and accompanying Series A and Series B warrants to purchase up to 89,284 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant. F1 · derivative.underlying: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer. Read SEC document |
| March 06, 2025 Filed Apr 29, 2025 21:00 UTC |
Patel Sandip IDirector
|
GrantAmerican Depositary Shares representing Ordinary Shares | 44,642 | $1.12 | $49,999.04 |
DisclosureSEC source: 0000950170-25-060298 · ownership.xml · nonDerivative · entry 1 Patel Sandip I · CIK 0001843601 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 496,499 F1 · security: Each American Depositary Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer. F2 · kind: On April 25, 2025, the Reporting Person acquired 44,642 ADS and accompanying Series A and Series B warrants to purchase up to 89,284 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant. F2 · price: On April 25, 2025, the Reporting Person acquired 44,642 ADS and accompanying Series A and Series B warrants to purchase up to 89,284 ADS in a private placement by the Issuer pursuant to the terms of a Securities Purchase Agreement dated as of February 27, 2025. The combined purchase price was $1.12 per ADS and accompanying Series A and Series B warrant. Read SEC document |
| January 10, 2025 Filed Jan 13, 2025 13:05 UTC |
Gaslightwala AbizerDirector
|
GrantAmerican Depository Shares representing Ordinary Shares | 11,439 | $1.22 | $13,955.58 |
DisclosureSEC source: 0000950170-25-004580 · ownership.xml · nonDerivative · entry 1 Gaslightwala Abizer · CIK 0002049375 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,860 F1 · security: Each American Depository Share ("ADS") represents 2,000 Ordinary Shares with a par value of $0.0001 per Ordinary Share of the Issuer. F2 · kind: On January 10, 2025, the Reporting Person acquired 11,439 ADS at purchase price of $1.22 per ADS. F2 · price: On January 10, 2025, the Reporting Person acquired 11,439 ADS at purchase price of $1.22 per ADS. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.